{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T23:46:41Z","timestamp":1777420001599,"version":"3.51.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,6,10]],"date-time":"2016-06-10T00:00:00Z","timestamp":1465516800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Pediatr"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1007\/s12519-016-0036-8","type":"journal-article","created":{"date-parts":[[2016,6,10]],"date-time":"2016-06-10T10:29:03Z","timestamp":1465554543000},"page":"443-449","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Prescription trends in children with pervasive developmental disorders: a claims data-based study in Japan"],"prefix":"10.1007","volume":"12","author":[{"given":"Michihiro","family":"Satoh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taku","family":"Obara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidekazu","family":"Nishigori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiro","family":"Ooba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiko","family":"Morikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mami","family":"Ishikuro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirohito","family":"Metoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Kikuya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nariyasu","family":"Mano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,6,10]]},"reference":[{"key":"36_CR1","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed, Text Revision (DSMIVTR). Arlington, VA: American Psychiatric Publishing, Inc, 2000."},{"key":"36_CR2","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1542\/peds.2005-2993","volume":"118","author":"E Fombonne","year":"2006","unstructured":"Fombonne E, Zakarian R, Bennett A, Meng L, McLean-Heywood D. Pervasive developmental disorders in Montreal, Quebec, Canada: prevalence and links with immunizations. Pediatrics 2006;118:e139\u2013e150.","journal-title":"Pediatrics"},{"key":"36_CR3","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00788743","volume":"28","author":"A Janca","year":"1993","unstructured":"Janca A, Ustun TB, Early TS, Sartorius N. The ICD-10 symptom checklist: a companion to the ICD-10 classification of mental and behavioural disorders. Soc Psychiatry Psychiatr Epidemiol 1993;28:239\u2013242.","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"36_CR4","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1542\/peds.2007-2361","volume":"120","author":"CP Johnson","year":"2007","unstructured":"Johnson CP, Myers SM. Identification and evaluation of children with autism spectrum disorders. Pediatrics 2007;120:1183\u20131215.","journal-title":"Pediatrics"},{"key":"36_CR5","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1440-1819.2008.01748.x","volume":"62","author":"Y Kawamura","year":"2008","unstructured":"Kawamura Y, Takahashi O, Ishii T. Reevaluating the incidence of pervasive developmental disorders: impact of elevated rates of detection through implementation of an integrated system of screening in Toyota, Japan. Psychiatry Clin Neurosci 2008;62:152\u2013159.","journal-title":"Psychiatry Clin Neurosci"},{"key":"36_CR6","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/B978-0-444-52002-9.00023-1","volume":"106","author":"J McPartland","year":"2012","unstructured":"McPartland J, Volkmar FR. Autism and related disorders. Handbook of clinical neurology 2012;106:407\u2013418.","journal-title":"Handbook of clinical neurology"},{"key":"36_CR7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1172\/JCI32483","volume":"118","author":"DJ Posey","year":"2008","unstructured":"Posey DJ, Stigler KA, Erickson CA, McDougle CJ. Antipsychotics in the treatment of autism. J Clin Invest 2008;118:6\u201314.","journal-title":"J Clin Invest"},{"key":"36_CR8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4137\/CMPed.S8304","volume":"8","author":"E Kirino","year":"2014","unstructured":"Kirino E. Efficacy and tolerability of pharmacotherapy options for the treatment of irritability in autistic children. Clin Med Insights Pediatr 2014;8:17\u201330.","journal-title":"Clin Med Insights Pediatr"},{"key":"36_CR9","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1089\/cap.2005.15.116","volume":"15","author":"MG Aman","year":"2005","unstructured":"Aman MG, Lam KS, van Bourgondien ME. Medication patterns in patients with autism: temporal, regional, and demographic influences. J Child Adolesc Psychopharmacol 2005;15:116\u2013126.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"36_CR10","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ridd.2004.12.002","volume":"27","author":"VA Green","year":"2006","unstructured":"Green VA, Pituch KA, Itchon J, Choi A, O\u2019Reilly M, Sigafoos J. Internet survey of treatments used by parents of children with autism. Res Dev Disabil 2006;27:70\u201384.","journal-title":"Res Dev Disabil"},{"key":"36_CR11","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1089\/cap.2006.17303","volume":"17","author":"DP Oswald","year":"2007","unstructured":"Oswald DP, Sonenklar NA. Medication use among children with autism spectrum disorders. J Child Adolesc Psychopharmacol 2007;17:348\u2013355.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"36_CR12","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s10803-009-0878-1","volume":"40","author":"RE Rosenberg","year":"2010","unstructured":"Rosenberg RE, Mandell DS, Farmer JE, Law JK, Marvin AR, Law PA. Psychotropic medication use among children with autism spectrum disorders enrolled in a national registry, 2007-2008. J Autism Dev Disord 2010;40:342\u2013351.","journal-title":"J Autism Dev Disord"},{"key":"36_CR13","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1089\/cap.2005.15.671","volume":"15","author":"A Witwer","year":"2005","unstructured":"Witwer A, Lecavalier L. Treatment incidence and patterns in children and adolescents with autism spectrum disorders. J Child Adolesc Psychopharmacol 2005;15:671\u2013681.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"36_CR14","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2188\/jea.JE20090066","volume":"20","author":"S Kimura","year":"2010","unstructured":"Kimura S, Sato T, Ikeda S, Noda M, Nakayama T. Development of a database of health insurance claims: standardization of disease classifications and anonymous record linkage. J Epidemiol 2010;20:413\u2013419.","journal-title":"J Epidemiol"},{"key":"36_CR15","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/DBP.0b013e3182040acf","volume":"32","author":"LC Huffman","year":"2011","unstructured":"Huffman LC, Sutcliffe TL, Tanner IS, Feldman HM. Management of symptoms in children with autism spectrum disorders: a comprehensive review of pharmacologic and complementary-alternative medicine treatments. J Dev Behav Pediatr 2011;32:56\u201368.","journal-title":"J Dev Behav Pediatr"},{"key":"36_CR16","first-page":"CD009043","volume":"5","author":"H Ching","year":"2012","unstructured":"Ching H, Pringsheim T. Aripiprazole for autism spectrum disorders (ASD). Cochrane Database Syst Rev 2012;5:CD009043.","journal-title":"Cochrane Database Syst Rev"},{"key":"36_CR17","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00787-004-0391-1","volume":"13","author":"Y Yoshida","year":"2004","unstructured":"Yoshida Y, Uchiyama T. The clinical necessity for assessing Attention Deficit\/Hyperactivity Disorder (AD\/HD) symptoms in children with high-functioning Pervasive Developmental Disorder (PDD). Eur Child Adolesc Psychiatry 2004;13:307\u2013314.","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"36_CR18","doi-asserted-by":"crossref","first-page":"I80","DOI":"10.1007\/s00787-004-1008-4","volume":"13","author":"C Gillberg","year":"2004","unstructured":"Gillberg C, Gillberg IC, Rasmussen P, Kadesjo B, Soderstrom H, Rastam M, et al. Co-existing disorders in ADHD \u2014implications for diagnosis and intervention. Eur Child Adolesc Psychiatry 2004;13 Suppl 1:I80\u2013I92.","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"36_CR19","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10803-005-0060-3","volume":"36","author":"KD Gadow","year":"2006","unstructured":"Gadow KD, De Vincent CJ, Pomeroy J. ADHD symptom subtypes in children with pervasive developmental disorder. J Autism Dev Disord 2006;36:271\u2013283.","journal-title":"J Autism Dev Disord"},{"key":"36_CR20","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s10803-006-0123-0","volume":"36","author":"OT Leyfer","year":"2006","unstructured":"Leyfer OT, Folstein SE, Bacalman S, Davis NO, Dinh E, Morgan J, et al. Comorbid psychiatric disorders in children with autism: interview development and rates of disorders. J Autism Dev Disord 2006;36:849\u2013861.","journal-title":"J Autism Dev Disord"},{"key":"36_CR21","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/tpj.2009.63","volume":"10","author":"CT Correia","year":"2010","unstructured":"Correia CT, Almeida JP, Santos PE, Sequeira AF, Marques CE, Miguel TS, et al. Pharmacogenetics of risperidone therapy in autism: association analysis of eight candidate genes with drug efficacy and adverse drug reactions. Pharmacogenomics J 2010;10:418\u2013430.","journal-title":"Pharmacogenomics J"},{"key":"36_CR22","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/tpj.2011.23","volume":"12","author":"L Lit","year":"2012","unstructured":"Lit L, Sharp FR, Bertoglio K, Stamova B, Ander BP, Sossong AD, et al. Gene expression in blood is associated with risperidone response in children with autism spectrum disorders. Pharmacogenomics J 2012;12:368\u2013371.","journal-title":"Pharmacogenomics J"},{"key":"36_CR23","doi-asserted-by":"crossref","first-page":"85S","DOI":"10.1097\/00004583-199710001-00007","volume":"36","author":"M Dulcan","year":"1997","unstructured":"Dulcan M. Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit\/hyperactivity disorder. American Academy of Child and Adolescent Psychiatry. J Am Acad Child Adolesc Psychiatry 1997;36:85S\u2013121S.","journal-title":"American Academy of Child and Adolescent Psychiatry. J Am Acad Child Adolesc Psychiatry"},{"key":"36_CR24","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/mpr.1444","volume":"23","author":"AJ Baxter","year":"2014","unstructured":"Baxter AJ, Vos T, Scott KM, Norman RE, Flaxman AD, Blore J, et al. The regional distribution of anxiety disorders: implications for the Global Burden of Disease Study, 2010. Int J Methods Psychiatr Res 2014;23:422\u2013438.","journal-title":"Int J Methods Psychiatr Res"}],"container-title":["World Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-016-0036-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12519-016-0036-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-016-0036-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T12:04:44Z","timestamp":1656677084000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12519-016-0036-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,10]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["36"],"URL":"https:\/\/doi.org\/10.1007\/s12519-016-0036-8","relation":{},"ISSN":["1708-8569","1867-0687"],"issn-type":[{"value":"1708-8569","type":"print"},{"value":"1867-0687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,10]]}}}